Physiological functions and clinical implications of fibrinogen-like 2: A review

This publication has 74 references indexed in Scilit:

• Increased circulating fibrinogen-like protein 2 in patients with systemic sclerosis
  Clinical Rheumatology, 2012
• Programmed Death (PD)-1-Deficient Mice Are Extremely Sensitive to Murine Hepatitis Virus Strain-3 (MHV-3) Infection
  PLOS Pathogens, 2011
• Dual Interference with Novel Genes mfgl2 and mTNFR1 Ameliorates Murine Hepatitis Virus Type 3-Induced Fulminant Hepatitis in BALB/cJ Mice
  Human Gene Therapy, 2010
• The FGL2/fibroleukin prothrombinase is involved in alveolar macrophage activation in COPD through the MAPK pathway
  Biochemical and Biophysical Research Communications, 2010
• Microarray Analysis of Lymphatic Tissue Reveals Stage-Specific, Gene Expression Signatures in HIV-1 Infection
  The Journal of Immunology, 2009
• The novel CD4+CD25+ regulatory T cell effector molecule fibrinogen-like protein 2 contributes to the outcome of murine fulminant viral hepatitis #
  Hepatology, 2009
• Fgl2deficiency causes neonatal death and cardiac dysfunction during embryonic and postnatal development in mice
  Physiological Genomics, 2007
• MurineHepatitis Virus Strain 1 Produces a Clinically Relevant Model of Severe Acute Respiratory Syndrome in A/J Mice
  Journal of Virology, 2006
• Genomic Characterization, Localization, and Functional Expression of FGL2, the Human Gene Encoding Fibroleukin: A Novel Human Procoagulant
  Genomics, 2001
• The Emerging Role of Immunoregulation of Fibrinogen‐Related Procoagulant Fgl2 in the Success or Spontaneous Abortion of Early Pregnancy in Mice and Humans
  American Journal of Reproductive Immunology, 1999